Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Nutt

Showing results (171-180 of 179) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 179 results.
Cureus|February 3, 2025
Correction: Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'Sorcha O'Connor, Kate Godfrey, Sara Reed, et al.
Cureus|January 30, 2025
Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'Sorcha O'Connor, Kate Godfrey, Sara Reed, et al.
Biological Psychiatry|February 21, 2017
Nalmefene Reduces Reward Anticipation in Alcohol Dependence: An Experimental Functional Magnetic Resonance Imaging StudyDarren R Quelch, Inge Mick, John McGonigle, et al.
Journal of Psychopharmacology (Oxford, England)|January 27, 2026
Drug harms in Canada: A multi-criteria decision analysisJean-François Crépault, Cayley Russell, Mark Asbridge, et al.
Journal of Psychopharmacology (Oxford, England)|June 24, 2023
The New Zealand drug harms ranking study: A multi-criteria decision analysisRose Crossin, Lana Cleland, Chris Wilkins, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|July 16, 2016
Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognitionBorwin Bandelow, David Baldwin, Marianna Abelli, et al.
Human Molecular Genetics|October 11, 2017
A point mutation in the ion conduction pore of AMPA receptor GRIA3 causes dramatically perturbed sleep patterns as well as intellectual disabilityBenjamin Davies, Laurence A Brown, Ondrej Cais, et al.
Molecular Psychiatry|December 15, 2021
A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trialsLuca Sforzini, Courtney Worrell, Melisa Kose, et al.
Nature Genetics|May 19, 2015
Factors influencing success of clinical genome sequencing across a broad spectrum of disordersJenny C Taylor, Hilary C Martin, Stefano Lise, et al.
Pageof 18

Showing results (171-180 of 179) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 179 results.
Cureus|February 3, 2025
Correction: Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'Sorcha O'Connor, Kate Godfrey, Sara Reed, et al.
Cureus|January 30, 2025
Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'Sorcha O'Connor, Kate Godfrey, Sara Reed, et al.
Biological Psychiatry|February 21, 2017
Nalmefene Reduces Reward Anticipation in Alcohol Dependence: An Experimental Functional Magnetic Resonance Imaging StudyDarren R Quelch, Inge Mick, John McGonigle, et al.
Journal of Psychopharmacology (Oxford, England)|January 27, 2026
Drug harms in Canada: A multi-criteria decision analysisJean-François Crépault, Cayley Russell, Mark Asbridge, et al.
Journal of Psychopharmacology (Oxford, England)|June 24, 2023
The New Zealand drug harms ranking study: A multi-criteria decision analysisRose Crossin, Lana Cleland, Chris Wilkins, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|July 16, 2016
Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognitionBorwin Bandelow, David Baldwin, Marianna Abelli, et al.
Human Molecular Genetics|October 11, 2017
A point mutation in the ion conduction pore of AMPA receptor GRIA3 causes dramatically perturbed sleep patterns as well as intellectual disabilityBenjamin Davies, Laurence A Brown, Ondrej Cais, et al.
Molecular Psychiatry|December 15, 2021
A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trialsLuca Sforzini, Courtney Worrell, Melisa Kose, et al.
Nature Genetics|May 19, 2015
Factors influencing success of clinical genome sequencing across a broad spectrum of disordersJenny C Taylor, Hilary C Martin, Stefano Lise, et al.
Pageof 18